Given the increased recognition of the similarities between lung cancer and IPF, more and more studies focused on the role of the PD-1/PD-L1 axis in IPF and investigated the potential therapeutic effect of PD-1/PD-L1 blockades on IPF. This evidence concerns the gene RPL17 and lung cancer.